Siren Biotechnology Secures $8 Million CIRM Grant to Advance Brain Cancer Gene Therapy

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer,  announced that the California Institute for Regenerative Medicine (C...

June 29, 2026 | Monday | News
AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening and Survivorship Support

Five-year, multimillion-dollar partnership kicks off with cancer screening and early detection education initiative in 75 communities AstraZen...

June 26, 2026 | Friday | News
Elevar Doses First Patients in Global Phase 2 Study of Lirafugratinib Across FGFR2-Driven Solid Tumors

First patient was dosed at Samsung Medical Center in Seoul, South Korea; a second at Moffitt Cancer Center in Tampa, Florida Global multi-site st...

June 24, 2026 | Wednesday | News
Sonire Therapeutics Secures $13 Million NEDO Grant to Accelerate Commercialization of Ultrasound-Guided HIFU Cancer Therapy

Non-dilutive funding will support the commercialization, development, and expansion strategy for Sonire's Ultrasound-Guided HIFU Platform Sonire Therape...

June 19, 2026 | Friday | News
Biogen to Acquire RayThera in Deal Worth Up to $1 Billion to Strengthen Immunology Pipeline

Biogen Inc. (Nasdaq: BIIB) and RayThera Inc., a private biotechnology company focused on discovering and developing small molecule therapies in immunolog...

June 19, 2026 | Friday | News
Lonza and Antharis Therapeutics Partner to Develop Next-Generation Dual-Payload ADCs for GI Cancers

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) progra...

June 17, 2026 | Wednesday | News
Hartwig Expands Partnership with Ultima Genomics to Advance Clinical Whole-Genome Sequencing in Oncology

Hartwig to adopt Ultima Genomics' UG200 sequencing system to accelerate implementation of whole-genome-based clinical genomics workflows on Solaris 2.0 t...

June 15, 2026 | Monday | News
Roche Secures EU IVDR Approval for Expanded VENTANA MMR RxDx Panel Across Multiple Solid Tumour Indications

Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment ...

June 15, 2026 | Monday | News
Anocca Doses First Patients with KRAS-Targeted TCR-T Therapy in Pancreatic Cancer Trial

Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, announc...

June 12, 2026 | Friday | News
Lung Cancer Research Foundation and AstraZeneca Launch Research Awards to Advance Small Cell Lung Cancer Treatment and Patient Advocacy

The Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca,  announced that two research awards focused on improving outcomes for...

June 11, 2026 | Thursday | News
Harbour BioMed Secures China IND Acceptance for HBM7004 in Advanced Solid Tumors

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics...

June 11, 2026 | Thursday | News
Strengthening the Foundation of Oncology Real-World Evidence Through Better Data Quality

As real-world evidence assumes a growing role in oncology research, regulatory evaluation, and clinical decision-making, the quality of underlying data has...

June 09, 2026 | Tuesday | Expert Opinion
Expanding Access to Cancer Care Through Advanced Practice Provider-Led Models

As oncology practices face increasing patient demand and looming workforce shortages, advanced practice providers (APPs) are becoming an essential part of ...

June 08, 2026 | Monday | Expert Opinion
Transforming Oncology Care Through Remote Monitoring and Patient-Reported Outcomes

As oncology care becomes increasingly personalized and technology-enabled, digital tools are playing a growing role in improving patient outcomes beyond th...

June 08, 2026 | Monday | Expert Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close